December 17th, 2010
FDA Approves Cryoballoon Ablation Treatment for Paroxysmal AF
Larry Husten, PHD
Medtronic announced today that it has received FDA approval for its Arctic Front® Cardiac CryoAblation Catheter system for the treatment of refractory paroxysmal AF.
One Response to “FDA Approves Cryoballoon Ablation Treatment for Paroxysmal AF”
NEJM Journal Watch — Recent Cardiology Articles- Persistent Symptoms After Valve Replacement for Severe Aortic Stenosis
- Is Diltiazem Safe in Patients with AF Taking Apixaban or Rivaroxaban?
- Does Lowering High Childhood Lipid Levels Prevent Adverse Cardiovascular Events in Adulthood?
- Self-Expanding Supraannular Valve vs. Balloon-Expandable Valve in TAVR for Small Aortic Annulus
- A New TAVR Prosthesis for Aortic Regurgitation Shows Promise
Probably makes slightly more sense to be more circumspect and careful with an anti-platelet drug which will likely have a much wider clientele than a modality of therapy for paroxysmal resistant afib….